Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

Esther E. E. Drees; Yvonne W. S. Jauw; Erik van Dijk; Sven Borchmann; Sandra A. W. M. Verkuijlen; Phylicia Stathi; Nils J. Groenewegen; Nathalie J. Hijmering; Daniella R. A. I. Berry; Eric J. Meershoek; Danielle Hoogmoed; Anne Kwakman; Tessa J. Molenaar; Dirk M. Pegtel; Bauke Ylstra; Daphne de Jong; Josée M. Zijlstra; Margaretha G. M. Roemer

doi:10.1097/HS9.0000000000000749

Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

Esther E. E. Drees
, Yvonne W. S. Jauw
, Erik van Dijk
, Sven Borchmann
, Sandra A. W. M. Verkuijlen
, Phylicia Stathi
, Nils J. Groenewegen
, Nathalie J. Hijmering
, Daniella R. A. I. Berry
, Eric J. Meershoek
, Danielle Hoogmoed
, Anne Kwakman
, Tessa J. Molenaar
, Dirk M. Pegtel
, Bauke Ylstra
, Daphne de Jong
, Josée M. Zijlstra^*
, Margaretha G. M. Roemer

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Downloads (Pure)

Original language	English
Pages (from-to)	E749
Journal	HemaSphere
Volume	6
Issue number	7
DOIs	https://doi.org/10.1097/HS9.0000000000000749
Publication status	Published - 4 Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/HS9.0000000000000749

Blood-based-monitoring-of-relapsedrefractory-hodgkin-lymphoma-patients-predict-responses-to-anti-pd-1-treatment.pdfFinal published version, 4.46 MBLicence: CC BY

Cite this

Drees, E. E. E., Jauw, Y. W. S., van Dijk, E., Borchmann, S., Verkuijlen, S. A. W. M., Stathi, P., Groenewegen, N. J., Hijmering, N. J., Berry, D. R. A. I., Meershoek, E. J., Hoogmoed, D., Kwakman, A., Molenaar, T. J., Pegtel, D. M., Ylstra, B., de Jong, D., Zijlstra, J. M., & Roemer, M. G. M. (2022). Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment. HemaSphere, 6(7), E749. https://doi.org/10.1097/HS9.0000000000000749

@article{7c4f4eb20682412d9ad249c180dcb1e6,

title = "Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment",

author = "Drees, \{Esther E. E.\} and Jauw, \{Yvonne W. S.\} and \{van Dijk\}, Erik and Sven Borchmann and Verkuijlen, \{Sandra A. W. M.\} and Phylicia Stathi and Groenewegen, \{Nils J.\} and Hijmering, \{Nathalie J.\} and Berry, \{Daniella R. A. I.\} and Meershoek, \{Eric J.\} and Danielle Hoogmoed and Anne Kwakman and Molenaar, \{Tessa J.\} and Pegtel, \{Dirk M.\} and Bauke Ylstra and \{de Jong\}, Daphne and Zijlstra, \{Jos{\'e}e M.\} and Roemer, \{Margaretha G. M.\}",

year = "2022",

month = jul,

day = "4",

doi = "10.1097/HS9.0000000000000749",

language = "English",

volume = "6",

pages = "E749",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

Drees, EEE , Jauw, YWS, van Dijk, E, Borchmann, S, Verkuijlen, SAWM, Stathi, P, Groenewegen, NJ, Hijmering, NJ, Berry, DRAI, Meershoek, EJ, Hoogmoed, D, Kwakman, A, Molenaar, TJ, Pegtel, DM , Ylstra, B , de Jong, D , Zijlstra, JM & Roemer, MGM 2022, 'Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment', HemaSphere, vol. 6, no. 7, pp. E749. https://doi.org/10.1097/HS9.0000000000000749

TY - JOUR

T1 - Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

AU - Drees, Esther E. E.

AU - Jauw, Yvonne W. S.

AU - van Dijk, Erik

AU - Borchmann, Sven

AU - Verkuijlen, Sandra A. W. M.

AU - Stathi, Phylicia

AU - Groenewegen, Nils J.

AU - Hijmering, Nathalie J.

AU - Berry, Daniella R. A. I.

AU - Meershoek, Eric J.

AU - Hoogmoed, Danielle

AU - Kwakman, Anne

AU - Molenaar, Tessa J.

AU - Pegtel, Dirk M.

AU - Ylstra, Bauke

AU - de Jong, Daphne

AU - Zijlstra, Josée M.

AU - Roemer, Margaretha G. M.

PY - 2022/7/4

Y1 - 2022/7/4

UR - https://www.scopus.com/pages/publications/85179079576

U2 - 10.1097/HS9.0000000000000749

DO - 10.1097/HS9.0000000000000749

M3 - Comment/Letter to the editor

C2 - 35813096

SN - 2572-9241

VL - 6

SP - E749

JO - HemaSphere

JF - HemaSphere

IS - 7

ER -

Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

UN SDGs

Access to Document

Other files and links

Cite this